<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ISOETHARINE HYDROCHLORIDE</span><br/>(eye-soe-eth'a-reen)<br/><span class="topboxtradename">Arm-a-Med Isoetharine, </span><span class="topboxtradename">Beta-2, </span><span class="topboxtradename">Bronkosol, </span><span class="topboxtradename">Dey-Lute, </span><span class="topboxtradename">Dispos-a-Med Isoetharine<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">beta-adrenergic agonist (sympathomimetic)</span>; <span class="classification">bronchodilator</span><br/><b>Prototype: </b>Albuterol<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1% solution</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic sympathomimetic stimulant with relatively rapid onset and long duration of action. Has selective affinity for beta<sub>2</sub> adreno-receptors on bronchial and selected arteriolar musculature.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Relieves reversible bronchospasm and by bronchodilation facilitates expectoration of pulmonary secretions. Increases vital
         capacity and decreases airway resistance.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Bronchial asthma and reversible bronchospasm occurring with bronchitis and emphysema.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Known hypersensitivity to sympathomimetic amines and to bisulfites; concomitant use with epinephrine or other sympathomimetic
         amines; patients with preexisting cardiac arrhythmias associated with tachycardia. Use during pregnancy (category C) or lactation
         requires judgment of risk/benefit ratio.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Older adults; hypertension; acute coronary artery disease; CHF; cardiac asthma; hyperthyroidism, diabetes mellitus; tuberculosis;
         history of seizures.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Bronchospasm</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Inhalation</span> 0.51 mL 0.5% or 0.5 mL 1% solution diluted 1:3 with normal saline or 24 mL 0.125% solution undiluted
               or 25 mL 0.2% solution undiluted or 2 mL 0.25% solution undiluted per nebulizer q4h (max: 5 times/d); 12
               inhalations from an MDI q4h up to 5 times/d<br/><span class="rdage">Child:</span> <span class="rdroute">Inhalation</span> 0.01 mL/kg of 1% solution (max: 0.5 mL) diluted in 23 mL normal saline<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Inhalation</span><br/><ul>
<li>Give on arising in morning and before meals to reduce fatigue from activity by improving lung ventilation.</li>
<li>Wait 1 full min after initial 1 or 2 inhalations (Bronkometer) to be sure of necessity for another dose. Action should begin
            immediately and peak within 515 min.
         </li>
<li>Alternate therapy with concurrent epinephrine administration but do not administer simultaneously because of danger of excessively
            rapid heartbeat.
         </li>
<li>Do not use discolored or precipitated solutions.</li>
<li>Protect solutions from light, freezing, and heat.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CV:</span> <span class="speceff-common">Tachycardia, palpitations,</span> changes in BP, <span class="speceff-life">cardiac arrest</span>. <span class="typehead">GI:</span> Nausea, vomiting. <span class="typehead">CNS:</span> Headache, <span class="speceff-common">anxiety,</span> tension, restlessness, insomnia, <span class="speceff-common">tremor,</span> weakness, dizziness, excitement. <span class="typehead">Respiratory:</span> Cough, bronchial irritation and edema; tachyphylaxis. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span> <b>Epinephrine,</b> other <span class="classification">sympathomimetic bronchodilators</span> possibly have additive effects; <span class="classification">mao inhibitors</span>, <span class="classification">tricyclic antidepressants</span> potentiate action on vascular system; effects of both <span class="classification">beta-adrenergic blockers</span> and isoetharine antagonized when given together. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> Immediate. <span class="typehead"> Peak:</span> 515 min. <span class="typehead"> Duration:</span> 14 h. <span class="typehead">Metabolism:</span> Metabolized in lungs, liver, GI tract, and other tissues. <span class="typehead">Elimination:</span> Excreted by kidneys. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Do not use this product if patient has a history of allergy to sulfite agents. The preservative sodium bisulfite is in the
            hydrochloride formulation.
         </li>
<li>Monitor cardiac status and report tachycardia and palpitations. Older adults may be especially sensitive to adrenergic drug
            effects.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Close eyes when actuating the nebulizer.</li>
<li>Use inhalation therapy according to prescribed regimen. Overuse may decrease desired effect and cause symptoms including tachycardia,
            palpitations, headache, nausea, dizziness.
         </li>
<li>Read information and instructions furnished with the aerosol form of isoetharine.</li>
<li>Increase daily fluid intake to aid in liquefaction of bronchial secretions.</li>
<li>Discontinue drug and notify physician if a sudden increase in dyspnea occurs.</li>
<li>Do not discard drug applicator. Refill units are available.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>